Search criteria | ||||
First Italian guidelines for the economic evaluation of health technologies: how do they compare to NICE standards? | ||||
Fiorentino F, Urbinati D | ||||
Fiorentino F: IQVIA Solutions Italy Srl, RWS | ||||
GIHTAD (2021) 14:5 |
||||
, Letter | ||||
, Italy | ||||
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/16/first-italian-guidelines-for-the-economic-evaluation-of-health-technologies-how-do-they-compare-to-nice-standards/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2021 | English | , Public Health | |
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee | ||||
Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1 | ||||
1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom | ||||
First published: 18 January 2020 https://doi.org/10.1002/cpt.1775 |
||||
, Abstract, Article | ||||
, France, Germany, UK | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Health policy | 2020 | English | , Retrospective database analysis | |
Who owns patient data? The answer is not that simple | ||||
Alison Bourke, Georgina Bourke | ||||
Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI. | ||||
BJMOpinion August 6, 2020 |
||||
, Article | ||||
, UK, USA | ||||
Abstract: https://blogs.bmj.com/bmj/2020/08/06/who-owns-patient-data-the-answer-is-not-that-simple/ | ||||
Condition | Year | Language | Analysis type | |
, COVID-19, Health policy | 2020 | English | , Market impact | |
Análisis de la implementación de los Informes de Posicionamiento Terapéutico en España | ||||
Míriam Solozabal, Laura Planellas, Elisabet Viayna, Neus Canal | ||||
Health Economics & Outcomes Research. Real-World Insights. IQVIA España | ||||
Revista Española de Economía de la Salud. 2019; 14(3):596-605 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.economiadelasalud.com/Articulo.aspx?i=v14n3d018 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement, Public Health | 2019 | Spanish | , Clinical setting: hospital, Clinical setting: Primary care, Internet or Interactive voice response system, Pricing & Reimbursement, Public Health | |
The impact of out-of-pocket spending on the preparation of generic drugs after the expiry of the market exclusivity | ||||
Cioni L1, Tettamanti A1, Urbinati D1 | ||||
IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Market impact, Public Health | |
Assessment of the oncological offer among Italian regions: a patient-centered analysis | ||||
Rova A1, Tettamanti A1, Pinto L1, Urbinati D1 | ||||
1 IQVIA, Milan, Italy | ||||
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Public Health | |
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE | ||||
Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi | ||||
Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands | ||||
Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019 |
||||
, Poster | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Musculoskeletal disease | 2019 | English | , Survey research | |
Determining Real-World Data’s Fitness for Use and the Role of Reliability | ||||
Nirosha Mahendraratnam Christina Silcox Kerra Mercon Adam Kroetsch Morgan Romine Nicholas Harrison Adam Aten Rachel Sherman Gregory Daniel* Mark McClellan | ||||
The Robert J. Margolis, MD, Center for Health Policy at Duke University is directed by Mark McClellan, MD, PhD, and brings together expertise from the Washington, DC, policy community, Duke University, and Duke Health to address the most pressing issues in health policy. The mission of Duke-Margolis is to improve health and the value of health care through practical, innovative, and evidence-based policy solutions. Duke-Margolis catalyzes Duke University’s leading capabilities, including interdisciplinary academic research and capacity for education and engagement, to inform policy making and implementation for better health and health care. For more information, visit healthpolicy.duke.edu. | ||||
https://healthpolicy.duke.edu/sites/default/files/atoms/files/_determining_real-world_datas_fitness_for_use_and_the_role_of_reliability.pdf |
||||
, Health authorities guidelines/assessment report, Report | ||||
Abstract: https://healthpolicy.duke.edu/publications/determining-real-world-data’s-fitness-use-and-role-reliability | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Health policy | 2019 | English | , Retrospective database analysis | |
Mid-upper arm circumference as a substitute of the body mass index for assessment of nutritional status among adult and adolescent females: learning from an impoverished Indian state. | ||||
Das A, Sai Mala G, Reddy N, Mishra P, Giri R, Kumar A, Raj A, Kumar G, Chaturvedi S, Babu S, Srikantiah S, Mahapatra T. | ||||
Lead author: Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (At the time of publication, the author was with CARE India Solutions for Sustainable Development) | ||||
Public Health |
||||
, Article | ||||
, India | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0033350619302963 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Nutritional Disorders | 2019 | English | , Cost minimization, Epidemiological study, Observational study, Population Based Study, Public Health | |
Where there is no nurse: an observational study of large-scale mentoring of auxiliary nurses to improve quality of care during childbirth at primary health centres in India. | ||||
Rao KD, Srivastava S, Warren N, Mayra K, Gore A, Das A, Ahmed S. | ||||
Lead author: Department of International Health, Johns Hopkins University Bloomberg School of Public Health. One of the contributing author is Aritra Das who is affiliated to Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (he was formerly with CARE India Solutions for Sustainable Development) | ||||
BMJ Open |
||||
, Article | ||||
, India | ||||
Abstract: https://bmjopen.bmj.com/content/bmjopen/9/7/e027147.full.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2019 | English | , Observational study, Public Health | |
The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly | ||||
Miao Jiang; Danny Hughes; Wenyi Wang | ||||
Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar) | ||||
Preventive Medicine |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries | ||||
Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy | ||||
Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA); | ||||
Radiology |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
The impact of the new innovative algorithm in Italy | ||||
Rova A1, Cioni L1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Public Health, Regulatory | 2018 | English | ||
The evolution of standard monitoring registries in the Italian market | ||||
Cioni L1, Rova A1, Urbinati D1 | ||||
1 IQVIA, RWI, Milan, Italy | ||||
ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Public Health, Regulatory | 2018 | English | ||
Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG | ||||
Fischer T, Bonduelle D, Antoni B | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2018 | German | , Market impact | |
Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considered by Federal Joint Committee for Determining the Appropriate Comparator? | ||||
Scheler E, Stratil AS, Roxlau T, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Health policy | 2018 | German | , Review | |
Success Factors for §137h SGB V Assessment of Medical Devices in Germany | ||||
Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2018 | English | , Review | |
Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment | ||||
Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria | ||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Pricing and reimbursement | 2018 | English | , Pricing & Reimbursement, Review | |
The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases | ||||
Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement | 2018 | English | , Cost analysis, Pricing & Reimbursement | |
Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany | ||||
Gohlke A, Kostev K, Kuschel AS | ||||
IQVIA Commercial GmbH & Co. OHG, Munich, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pediatrics, Regulatory | 2018 | English | , Utility analysis | |
Valoración de la innovación, ¿es “el innovómetro” una herramienta útil y su clasificación reproducible? | ||||
Otermin A, Callejo D, Gasche D, Viayna E, Rubio M, Sumalla M, Solozabal M. | ||||
HEOR-RWI, IQVIA | ||||
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018 |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2018 | Spanish | , Pricing & Reimbursement | |
Regional policies impact on biosimilar adoption for autoimmune diseases in Italy | ||||
Tucci C1, Rova A1, Mantuano M1, Tettamanti A1 | ||||
QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Gastrointestinal disorders, Health policy, Rheumatology | 2017 | English | , Literature Review | |
The impact of managed entry agreements on drug time to market in Italy | ||||
Mantuano M1, Rova A1, Urbinati D1 | ||||
1 QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Regulatory | 2017 | English | , Literature Review | |
The impact of biosimilar launch on molecule price and pharmaceutical expense: the case of the insulin glargine in Italy | ||||
Tucci C1, Cioni L1, Mantuano M1, Tettamanti A1 | ||||
1 QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health policy, Pricing and reimbursement, Regulatory | 2017 | English | , Literature Review, Pricing & Reimbursement, Public Health | |
Drug commercialization before the pricing and reimbursement in Italy: the non negotiated C Class (C-nn) | ||||
Mantuano M1, Cioni L1 | ||||
1 QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement, Regulatory | 2017 | English | , Literature Review, Pricing & Reimbursement, Public Health | |
Centralization and complexity of drug market access process across Italian regions | ||||
Tucci C1, Cioni L1, Mantuano M1, Urbinati D1 | ||||
QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Public Health, Regulatory | 2017 | English | , Literature Review, Public Health, Survey research | |
The impact of physician-level drug budgets on prescribing behaviour | ||||
Fischer KE; Koch T; Kostev K; Stargardt T | ||||
Eur J Health Econ. 2017 Feb 13. doi: 10.1007/s10198-017-0875-9. [Epub ahead of print] |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Health policy | 2017 | English | ||
Análisis de las diferencias en el tiempo de elaboración de los informes de posicionamiento terapéutico [Analysis of the differences in the time of elaboration of the reports of therapeutic positioning]. | ||||
Viayna E, Planellas L, Solozabal M | ||||
Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Literature Review, Public Health | |
Tiempos de Acceso Regional de Productos Hospitalarios [Regional Access Times for Hospital Products]. | ||||
Solozabal M1, Fraile S2, Gómez V1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis | |
Relación entre los tiempos del proceso de P&F y el acceso regional de productos hospitalarios en España [Relationship between the times of the P & F process and the regional access of hospital products in Spain]. | ||||
Gómez V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Oral presentation | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/es/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | Spanish | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Evolution of the time-to-market of hospital products in Spain. | ||||
Gómez-Navarro V1, Fraile S2, Solozabal M1 | ||||
1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, Spain | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2017 | English | , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research | |
Using Certification to Promote Uptake of Real-World Evidence by Payers | ||||
Jodi B. Segal, Joel D. Kallich, Emma R. Oppenheim, Louis P. Garrison Jr., Sheikh Usman Iqbal, Marla Kessler, G. Caleb Alexander | ||||
1Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2Principal, Big Health Data, Falmouth, Maine. 3Master’s Student, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4Professor of Pharmaceutical Outcomes Research and Policy, School of Pharmacy, University of Washington, Seattle. 5Senior Medical Affairs Leader−Neuroscience, Global Medical Affairs, AstraZeneca, Cambridge, Massachusetts. 6Vice President, Global Services and Real-World Evidence Solutions, IMS Health, Plymouth Meeting, Pennsylvania. 7Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Associate Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. | ||||
J Manag Care Spec Pharm, 2016 Mar;22(3):191-196. |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.18553/jmcp.2016.22.3.191 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health policy | 2016 | English | , Review | |
Italian electronic health records mapping: is clinical data collection getting in line with the real world evidence era? | ||||
Avitabile A, Caputo A, Gilardelli G, Golotta C, La Grasta L, Heiman F1, Porrello N. | ||||
1 IMS Health Information Solutions Italy Srl, Milan, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Neurological disorders, Oncology | 2016 | English | , Clinical setting: hospital, Real World Data, Real World Evidence | |
Comparison of biosimilar guideline and real consumption among Italian regions. | ||||
Tettamanti A1, Tucci C1, Urbinati D1. | ||||
1 IMS Health, Milan, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Health policy | 2016 | English | , Review | |
Regional market access pathways for diagnostics in Italy. | ||||
Mantuano M1, Dionisi M2, Paolini D2, Gancitano G2, Urbinati D1 | ||||
1 IMS Health, Milan, Italy 2 Roche Diagnostics, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement, Regulatory | 2016 | English | , Review | |
The impact of regional legislative measures on the prescription of off-patent medicines. | ||||
Tettamanti A1, Tucci C1, Urbinati D1. | ||||
IMS Health, Milan, Italy | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Health policy | 2016 | English | , Review | |
Regional time to market of innovative drugs in Italy. | ||||
Mantuano M1, Daniel F1, Urbinati D1. | ||||
IMS Health, Milan, Italy. | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2016 | English | , Review | |
Development and validation of an electronic frailty index using routine primary care electronic health record data | ||||
Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, Mohammed MA, Parry J, Marshall T | ||||
Academic Unit of Elderly Care and Rehabilitation, University of Leeds; ResearchOne, TPP, Leeds, West Yorkshire; Academic Unit of Elderly Care and Rehabilitation, University of Leeds; Institute of Applied Health Research, University of Birmingham; Faculty of Health Studies, University of Bradford; SystmOne, TPP, Leeds, West Yorkshire | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2016 | English | , Retrospective database analysis | |
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F. | ||||
Rheumatol Ther. 2016 Jun;3(1):53-75. |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Public Health | 2016 | English | , Retrospective cohort analysis | |
An audit of patients transferred out of The Health Improvement Network (THIN) – A UK primary care database | ||||
Myland M, Ansell D,Bourke A,Hill F,O’Leary C,Waples C,Nasser A | ||||
IMS Health | ||||
31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) Boston, USA |
||||
, Poster, Presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2015 | English | , Database Study, Retrospective database analysis | |
DOES CONDITIONAL MARKETING AUTHORISATION INFLUENCE MARKET ACCESS IN FRANCE, ENGLAND, AND GERMANY? | ||||
Kaaniche A1, Troubat A1, Sherwood A2 | ||||
1IMS, PARIS, France, 2IMS Health, La Défense, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Abstract, Poster | ||||
, France, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2015 | English | , Market impact | |
LISTE-EN-SUS REFORM IN FRANCE - WHAT ARE THE CONSEQUENCES? | ||||
Mitrano M, Flostrand S | ||||
IMS Consulting Group, Paris, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2015 | English | , Market impact | |
Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network | ||||
Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K & Norén GN | ||||
Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring | ||||
Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25539877 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2015 | English | , Retrospective database analysis | |
Audit of irreversible monoamine oxidase inhibitor (MAOI) prescribing for depression in current clinical practice using The Health Improvement Network (THIN) UK primary care database | ||||
Nasser A, O’Leary C, Myland M, Sam Waples S & Ansell D | ||||
IMS Health | ||||
ISPOR 20th Annual International Meeting, Philadelphia, USA PRIMM conference, 26th Annual Scientific Meeting, Imperial Hotel, Russell Square, London |
||||
, Poster | ||||
, UK | ||||
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health policy, Mental health | 2015 | English | , Retrospective database analysis | |
Longitudinal medical records as a complement to routine drug safety signal analysis | ||||
Star K, Watason S, Sandberg L, Johansson J, Edwards IR | ||||
Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring | ||||
Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd. 24(5):486-94 |
||||
, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.3739/full | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2015 | English | , Retrospective database analysis | |
Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN) | ||||
Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, Wood J, Gallagher AM, Bhullar H, Cardillo S, Hennessy S, Strom BL & Lo Re V 3rd | ||||
Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania | ||||
Pharmacoepidemiol Drug Safety Volume 24, Issue 9, pages 999–1003, |
||||
, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.3844/abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2015 | English | , Retrospective database analysis | |
Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report | ||||
Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2 | ||||
1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3 2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5 | ||||
Innovative Medicines Canada Annual Report 2016 |
||||
, Report | ||||
, Canada | ||||
Abstract: http://innovativemedicines.ca/wp-content/uploads/2016/05/20160524_Access_to_Medicines_Report_EN_Web.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2015 | English | , Review | |
(Supply profile of patients with occupational therapy regulations in their own practices) Versorgungsprofil der Patienten mit Ergotherapie-Verordnungen in niedergelassenen Praxen. | ||||
Kostev K1, Drosselmeyer2, Jockwig A2, Hog D2, Heilmaier C3 | ||||
1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 FOM University, Essen, Germany | ||||
Monitor Versorgungsforschung, 2014, Maerz. (02): |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | German | , Economic evaluation | |
Quantification of switching trends in the Greek pharmaceutical market during the period of crisis | ||||
Ollandezos M1, Charitonidis S2, Papadopoulos K1, Katsoulakis M2, Kofinas K2, Kyriopoulos J3 | ||||
1Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 2IMS Health Hellas, Athens, Greece, 3National School of Public Health, Athens, Greece | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Greece | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Methodology | |
Generic penetration within top-10 genericized molecules – Greece versus major European countries | ||||
Charitonidis S1, Kofinas K1, Katsoulakis M1, Papadopoulos K2, Ollandezos M2, Kyriopoulos J3 | ||||
1IMS Health Hellas, Athens, Greece, 2Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 3National School of Public Health, Athens, Greece | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Greece | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Pricing & Reimbursement | |
Trends in time to market access in Europe - is it getting better? | ||||
Flostrand SJ1, Lor S1, Anon Y2 | ||||
1IMS Consulting Group, La Défense Cedex, France, 2IMS Health, La Défense Cedex, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2014 | English | , Market impact | |
Trends in time to market access in Europe - is it getting better? | ||||
Flostrand SJ1, Lor S1, Anon Y2 | ||||
1IMS Consulting Group, La Défense Cedex, France, 2IMS Health, La Défense Cedex, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Market impact | |
Gender-related behaviors in drug consumption in Italy | ||||
Orlando V1, Bruzzese D2, Putignano D1, Guerriero F1, Tettamanti A3, Menditto E1 | ||||
1CIRFF- Center of Pharmacoeconomics, Naples, Italy, 2University of Naples, Federico II, Napoli, Italy, 3IMS Health, Milano, Italy | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Observational study | |
Quality of life – a rarely acknowledged key category within the AMNOG process in Germany | ||||
Eheberg D1, Shlaen R2, Batscheider A2, Gohlke A2 | ||||
1IMS Health, Munich, Germany, 2IMS Health, Munich, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Quality of life | |
Understanding the role of subgroup analysis and tests for homogeneity or interaction in the AMNOG dossier | ||||
Hofmann-Xu L1, Bonduelle D2, Eheberg D3 | ||||
IMS Health Germany, Munich, Germany, 2IMS HEALTH GmbH & Co. OHG, Munich, Germany, 3IMS HEALTH, Munich, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Methodology | |
First experiences with the new testing examination and treatment methods in Germany: Is this a new AMNOG clone? | ||||
Bonduelle D1, Eheberg D2, Plantoer S1 | ||||
1IMS Health GmbH & Co. OHG, Munich, Germany, 2IMS Health, Munich, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Market impact | |
Market access and reimbursement options for orphan drug hospital-only medicines in Europe – one size fits all? | ||||
Vosgerau S1, Paulus G1, Plantoer S2 | ||||
IMS Health, Munich, Germany, 2IMS HEALTH GmbH & Co. OHG, Munich, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Pricing & Reimbursement | |
Drug access through sharing public and individual responsibilities in the public healthcare system of Singapore | ||||
Tan SC1, Low PY2, Chia MX2 | ||||
1IMS Asia Pacific, Singapore, Singapore, 2IMS Health Asia, Singapore, Singapore | ||||
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
||||
, Poster | ||||
, Singapore | ||||
Abstract: http://www.ispor.org/Event/ProgramList/2014Beijing?type=Poster&sess=III&acode=PHP | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Review | |
Innovation in cancer care: Implications for global healthcare systems | ||||
Johnson K | ||||
Global Oncology, IMS Health, Plymouth Meeting, USA | ||||
AccessPoint, 2014, May; 4(8): 8-13 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2014 | English | , Real World Evidence | |
Future access to innovative oncology drugs in the EU: Evolution and proactive application of real-world evidence | ||||
McDonell A1, Opel M1, Berger K2 | ||||
1 IMS Health, London, UK 2 IMS Health, Munich, Germany | ||||
AccessPoint, 2014, May; 4(8): 32-35 |
||||
, Article | ||||
, Europe | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2014 | English | , Real World Evidence | |
ENCePP-HTA Working Group 2014 Survey of Members Experience in Conducting Research to Support HTA | ||||
Blake K1, Toussi M2, Kurz X1, Lis Y3, Ehrenstein V4, Qizilbash N5, Moore N 6 | ||||
1 European Medicines Agency, UK 2 IMS Health, Paris, France 3 PAREXEL International, Uxbridge, UK 4 Aarhus University Hospital, Denmark 5 OXON Epidemiology, Madrid, Spain 6 University of Bordeaux, France | ||||
30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Survey research | |
Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study | ||||
Marston L & Carpenter JR, Walters KR, Morris RW, Nazareth I, White IR & Petersen I | ||||
UCL Department of Primary Care and Population Health | ||||
BMJ Open2014;4:e004958 doi:10.1136/bmjopen-2014-004958 |
||||
, Article | ||||
, UK | ||||
Abstract: http://bmjopen.bmj.com/content/4/4/e004958.abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2014 | English | , Retrospective database analysis | |
Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data | ||||
O'Keeffe AG, Geneletti S, Baio G, Sharples LD, Nazareth I & Petersen I | ||||
Boston University School of Medicine Clinical Epidemiology Unit | ||||
BMJ 2014; 8;349:g5293 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.bmj.com/content/349/bmj.g5293 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Retrospective database analysis | |
Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data. | ||||
a,Catherine A. Welch 1, Irene Petersen1, Jonathan W. Bartlett 2, Ian R. White 3, Louise Marston 1, Richard W. Morris 1, Irwin Nazareth 1, Kate Walters 1 and James Carpenterb 1,4 | ||||
1, Department of Primary Care and Population Health, University College London (UCL), London, U.K. 2, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, U.K. 3, MRC Biostatistics Unit, Cambridge, U.K. 4, MRC Clinical Trials Unit, Aviation House, Kingsway, London, U.K | ||||
Statistics in Medicine Article first published online: 30 APR 2014 DOI: 10.1002/sim.6184 Statistics in Medicine 20;33(21):3725-37 |
||||
, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/sim.6184/abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Database Study, Retrospective database analysis | |
Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK. | ||||
McEwan P, Bennett H, Ward T & Bergenheim K | ||||
Swansea University1Swansea Centre for Health Economics | ||||
Pharmacoeconomics. 2015 Feb;33(2):149-61. doi: 10.1007/s40273-014-0225-z |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25344660 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health policy | 2014 | English | , Retrospective database analysis | |
Assessment of an incentivised scheme to provide annual health checks in primary care for adults with intellectual disability: a longitudinal cohort study | ||||
Buszewicz M, Welch C, Horsfall L, Nazareth I, Osborn D, et al. | ||||
UCL Research Department of Primary Care and Population Health | ||||
The Lancet Psychiatry 2014;1: 522–30 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(14)00079-0/abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Mental health | 2014 | English | , Retrospective database analysis | |
Using data envelopment analysis (DEA) to rank GP's according to their P4P quality and efficiency scores | ||||
Perronnin M, Pichetti S, Sermet C | ||||
Irdes, Paris, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Retrospective database analysis | |
Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–2012 | ||||
Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B | ||||
Disease Control and Health Promotion, Florida Department of Health | ||||
Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report (MMWR). July 4, 2014 / 63(26);569-574. |
||||
, Abstract | ||||
Abstract: http://origin.glb.cdc.gov/Mmwr/preview/mmwrhtml/mm6326a3.htm?s_cid=mm6326a3_w | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Mental health | 2014 | English | , Real World Evidence | |
The Effect of Competing Direct-to-Consumer Advertising Campaigns on the Use of Drugs for Benign Prostatic Hyperplasia: Time Series Analysis | ||||
Skeldon SC, Kozhimannil KB, Majumdar SR, Law MR | ||||
The University of British Columbia, Vancouver, BC | ||||
J GEN INTERN MED 2014;30(4):514-520. |
||||
, Abstract | ||||
Abstract: http://link.springer.com/article/10.1007/s11606-014-3063-y | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Urology | 2014 | English | , Real World Evidence | |
Fixed reference pricing or benefit assessment of established products –from the frying pan into the fire? | ||||
Vosgerau S1, Eheberg D1, Lebioda A1, Plantoer S1 | ||||
1 IMS Health, Munich, Germany | ||||
ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2013 | English | , Economic evaluation | |
A comparison of German benefit assessments by G-BA, IQWiG and manufacturers | ||||
Eheberg D1, Lebioda A1, Huelsebeck M1, Plantoer S1 | ||||
1 IMS Health, Munich, Germany | ||||
ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2013 | English | , Review | |
Relevance of indirect comparisons in the German early benefit assessment (AMNOG) | ||||
Lebioda A1, Gasche D2, Dippel FW 3, Plantoer S1 | ||||
1 IMS Health, Munich, Germany 2 IMS Health, Barcelona, Spain 3 Universitaet Leipzig, Leipzig, Germany | ||||
ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2013 | English | , Review | |
Understanding patterns of monitoring of appropriate prescribing in Europe | ||||
Schroeder C1, Keja J2, Toussi M3, Hughes B2 | ||||
1 IMS Health, Munich, Germany 2 IMS Health, London, UK 3 IMS Health, Paris, France | ||||
ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland |
||||
, Poster | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Regulatory | 2013 | English | , Review | |
Mortality and Medical Care after Bereavement: A General Practice Cohort Study | ||||
King M, Vasanthan M, Petersen I, Jones L, Marston L & Nazareth I | ||||
UCL Unit of Mental Health Sciences | ||||
PLoS One 8(1):e52561 DOI: 10.1371/journal.pone.0052561 |
||||
, Article | ||||
, UK | ||||
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052561 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2013 | English | , Retrospective database analysis | |
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort | ||||
Obiora E, Hubbard R, Sanders RD, Myles PR | ||||
Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK. | ||||
Thorax. 2013 Jun;68(6):591-2. doi: 10.1136/thoraxjnl-2013-203211. Epub 2013 Jan 31. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://thorax.bmj.com/content/68/6/591.2.extract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Respiratory disease | 2013 | English | , Retrospective database analysis | |
Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs. | ||||
Panca M, Cutting K & Guest JF. | ||||
Catalyst HealthEconomics Consultants | ||||
J Wound Care. 2013 Mar;22(3):109-10, 112-8. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23665729 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2013 | English | , Retrospective database analysis | |
Mortality in older care home residents in England and Wales. | ||||
Shah SM, Carey IM, Harris T, Dewilde S, Cook DG | ||||
St George's University of London Population Health Sciences and Education | ||||
Age Ageing. 2013 Mar;42(2):209-15. doi: 10.1093/ageing/afs174. Epub 2013 Jan 10. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23305759 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2013 | English | , Retrospective database analysis | |
Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records. | ||||
Douglas L & Szatkowski L | ||||
University of Nottingham UK Centre for Tobacco Control Studies | ||||
BMC Public Health 2013, 13:546 doi:10.1186/1471-2458-13-546 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2458/13/546 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2013 | English | , Retrospective database analysis | |
Alcohol consumption screening of newly-registered patients in primary care: a cross-sectional analysis. | ||||
Khadjesari Z, Marston L, Petersen I, Nazareth I & Walters K | ||||
UCL Primary Care and Population Health | ||||
Br J Gen Pract. 2013 Oct;63(615):e706-12. doi: 10.3399/bjgp13X673720. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24152486 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2013 | English | , Retrospective database analysis | |
Completeness of Maternal Smoking Status Recording during Pregnancy in United Kingdom Primary Care Data. | ||||
Dhalwani NN, Tata LJ, Coleman T, Fleming KM & Szatkowski L | ||||
University of Nottingham Division of Epidemiology and Public Health | ||||
Public Library of Science (PLoS one) 19;8(9):e72218 Public Library of Science (PLoS one) DOI: 10.1371/journal.pone.0072218 |
||||
, Article | ||||
, UK | ||||
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072218 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Womens Health | 2013 | English | , Retrospective database analysis | |
Potential of general practice data for congenital anomaly research: Comparison with registry data in the United Kingdom. | ||||
Sokal R, Fleming KM & Tata LJ | ||||
University of Nottingham Division of Epidemiology and Public Health | ||||
Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):546-53. doi: 10.1002/bdra.23150. Epub 2013 Aug 2. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23913362 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pediatrics | 2013 | English | , Retrospective database analysis | |
A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index | ||||
Carey IM, Shah SM, Harris T, Dewilde S & Cook DG | ||||
St George's University of London Division of Population Health Sciences and Education | ||||
Journal of Clinical Epidemiology 66(4):436-444 |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2013 | English | , Retrospective database analysis | |
The impact of the German pharmaceutical market reorganisation act (AMNOG) on the German reference price market – trends two years after the introduction of the AMNOG. | ||||
Eheberg D1, Batscheider A1, Lebioda A1, Plantoer S1, Fricke FU2 | ||||
1 IMS Health, Munich, Germany 2 Georg-Simon-Ohm-Hochschule Nuremberg | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2012 | English | , Market impact | |
How to optimise chances for successful AMNOG assessments – best practice approach for German market access. | ||||
Bonduelle D1, Huelsebeck M1, Plantoer S1 | ||||
1 IMS Health, Munich, Germany | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2012 | English | , Market impact | |
The responsible use of medicines | ||||
Aitken M1, Gorokhovich L2 | ||||
1IMS Health, Parsippany, USA, 2IMS Health, London, UK | ||||
AccessPoint, Nov 2012; Vol 3(5); 50-56 |
||||
, Article | ||||
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2012 | English | ||
Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database | ||||
Huang Y, Britton J, Hubbard R, Lewis S | ||||
University of Nottingham UK Centre for Tobacco Control Studies | ||||
Tob Control 22(4):274-9 Tob Control doi:10.1136/tobaccocontrol-2011-050124 |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://tobaccocontrol.bmj.com/content/early/2012/01/13/tobaccocontrol-2011-050124 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Accuracy of pneumonia hospital admissions in a primary care electronic medical record database. | ||||
Meropol SB & Metlay JP | ||||
Case Western Reserve University School of Medicine | ||||
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):659-65. doi: 10.1002/pds.3207. Epub 2012 Feb 28. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22374684 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Respiratory disease | 2012 | English | , Retrospective database analysis | |
Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK. | ||||
Guest JF, Taylor RR, Vowden K & Vowden P | ||||
Catalyst Health Economics Consultants | ||||
J Wound Care. 2012 Aug;21(8):389-94, 396-8. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22885312 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health policy | 2012 | English | , Retrospective database analysis | |
The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from The Health Improvement Network (THIN) database. | ||||
Taggar JS, Coleman T, Lewis S & Szatkowski L | ||||
University of Nottingham National School for Primary Care Research and UK Centre for Tobacco Control Studies | ||||
BMC Public Health 2012, 12:329 doi:10.1186/1471-2458-12-329 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2458/12/329 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet. | ||||
Guest JF, Bai JJ, Taylor RR, Sladkevicius E, Lee JP & Lachmann RH | ||||
Catalyst Health Economics Consultants | ||||
J Intellect Disabil Res. 2013 Jun;57(6):567-79. doi: 10.1111/j.1365-2788.2012.01568.x. Epub 2012 May 8. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22563770 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Quality of prescribing in care homes and the community in England and Wales | ||||
Shah SM, Carey IM, Harris T, DeWilde S & Cook DG | ||||
St George's University of London Division of Population Health Science and Education | ||||
Br J Gen Pract. 2012 May;62(598):e329-36. doi: 10.3399/bjgp12X641447. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338054/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Variation in recorded child maltreatment concerns in UK primary care records: a cohort study using The Health Improvement Network (THIN) database. | ||||
Woodman J, Freemantle N, Allister J, de Lusignan S, Gilbert R & Petersen I | ||||
UCL Medical Research Council-Centre of Epidemiology for Child Health | ||||
PLoS One 7(11):e49808 |
||||
, Article | ||||
, UK | ||||
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049808 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pediatrics | 2012 | English | , Retrospective database analysis | |
Pain-related pharmacotherapy, healthcare resource use and costs in spinal cord injury patients prescribed pregabalin. | ||||
Gore M, Brix F N, Sadosky A, Tai KS, Cappelleri JC, Mardekian J, George R C & Nieshoff E | ||||
Avalon Health Solutions | ||||
Spinal Cord. 2013 Feb;51(2):126-33. doi: 10.1038/sc.2012.97. Epub 2012 Sep 4. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22945747 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Neurological disorders | 2012 | English | , Retrospective database analysis | |
Identifying periods of acceptable computer usage in primary care research databases | ||||
Horsfall L, Walters K & Petersen I | ||||
UCL Research Department of Primary Care and Population Health | ||||
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):64-9. doi: 10.1002/pds.3368. Epub 2012 Nov 4. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23124958 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
A simple approach to improve recording of concerns about child maltreatment in primary care records: developing a quality improvement intervention. | ||||
Woodman J, Allister J, Rafi I, de Lusignan S, Belsey J, Petersen I & Gilbert R | ||||
UCL Institute of Child Health | ||||
Br J Gen Pract. 2012 Jul;62(600):e478-86. doi: 10.3399/bjgp12X652346. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22781996 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology, Pediatrics | 2012 | English | , Retrospective database analysis | |
Cost-effectiveness of using an extensively hydrolysed formula compared to an amino acid formula as first-line treatment for cow milk allergy in the UK. | ||||
Taylor RR, Sladkevicius E, Panca M, Lack G & Guest JF | ||||
Catalyst Health Economics Consultants | ||||
Pediatr Allergy Immunol. 2012 May;23(3):240-9. doi: 10.1111/j.1399-3038.2011.01262.x. Epub 2012 Feb 23. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22360663 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Drug utilisation adaptions in Sweden after the Effexor patent expiry | ||||
Bruce S, Hjelmgren J, Löfroth E, Myrén KJ. | ||||
IMS Consulting Group, Stockholm, Sweden. | ||||
ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain |
||||
, Poster | ||||
, Nordic, Sweden | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health policy, Mental health | 2011 | English | , Retrospective database analysis | |
Regional differences among Methadone maintenance programs in Spain | ||||
Vieta A, Hurtado P | ||||
IMS Health, Barcelona, Spain | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2011 | English | , Prospective study | |
Prescribing of smoking cessation medication in England since the introduction of varenicline | ||||
Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S | ||||
University of Nottingham UK Centre for Tobacco Control Studies, Division of Epidemiology and Public Health | ||||
Addiction Volume 106, Issue 7, pages 1319–1324, July 2011 |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2011.03426.x/abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Can data from primary care medical records be used to monitor national smoking prevalence? | ||||
Szatkowski L, Lewis S, McNeill A, Huang Y & Coleman T | ||||
Queen's Medical Centre Division of Primary Care | ||||
J Epidemiol Community Health. 2012 Sep;66(9):791-5. doi: 10.1136/jech.2010.120154. Epub 2011 May 13. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21571750 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2011 | English | , Retrospective database analysis | |
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England. | ||||
Szatkowski L, Coleman T, McNeill A, Lewis S | ||||
University of Nottingham UK Centre for Tobacco Control Studies | ||||
Addiction. 2011 Oct;106(10):1827-34. doi: 10.1111/j.1360-0443.2011.03494.x. Epub 2011 Jul 27 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21561500 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Respiratory disease | 2011 | English | , Retrospective database analysis | |
Prescribing compliance: a review of the proportion of prescriptions dispensed. | ||||
David L | ||||
Ninewells Hospital and Medical School Department of Pharmacology and Clinical Pharmacology | ||||
The Health and Social Care Information Centre, Publication date: September 07, 2011 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.hscic.gov.uk/pubs/presccompliance | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Medication compliance | 2011 | English | , Retrospective database analysis | |
Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. | ||||
Kirby MG, Schnetzler G, Zou KH & Symonds T | ||||
University of Hertfordshire Faculty of Health and Human Sciences | ||||
Int J Clin Pract. 2011 Jul;65(7):797-806. doi: 10.1111/j.1742-1241.2011.02693.x. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21676121 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Urology | 2011 | English | , Retrospective database analysis | |
Can primary care data be used to monitor regional smoking prevalence? An analysis of The Health Improvement Network primary care data. | ||||
Langley TE, Szatkowski LC, Wythe S & Lewis SA | ||||
University of Nottingham Division of Epidemiology and Public Health | ||||
BMC Public Health 2011, 11:773 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2458/11/773 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Better public health through pharmaco-epidemiology and quality use of medicine | ||||
Man SL | ||||
UCL | ||||
EuroDURG/ISPE - December 2011 University of Antwerp |
||||
, Poster | ||||
, UK | ||||
Abstract: http://archive-org.com/org/p/pcne.org/2012-12-22_1038749_11/Profile_of_jwfvmil/ | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Child maltreatment recording in primary care. | ||||
Woodman J, Gilbert R, Allister J, De Lusignan S, Rafi I & Petersen I | ||||
UCL | ||||
Society for Academic Primary Care (SAPC), SAPC Bristol 6-8 July 2011 |
||||
, Abstract, Conference | ||||
, UK | ||||
Abstract: https://sapc.conference-services.net/reports/template/onetextabstract.xml?xsl=template/onetextabstract.xsl&conferenceID=2491&abstractID=499392 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pediatrics | 2011 | English | , Retrospective database analysis | |
The impact of pneumococcal conjugate vaccination on primary care consultations in the UK. | ||||
Trotter C, Petersen I, Sterne J, Hayward A. | ||||
UCL | ||||
SAPC Annual Scientific Meeting,Bristol. 2011 |
||||
, Abstract, Conference, Poster | ||||
, UK | ||||
Abstract: https://sapc.conference-services.net/reports/template/onetextabstract.xml?xsl=template/onetextabstract.xsl&conferenceID=2491&abstractID=499554 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Immunology and Vaccination | 2011 | English | , Retrospective database analysis | |
Aut-idem und Rabattverträge - ein Garant für Kosteneinsparungen? [Me-too prescription and discount contracts - a guarantor for cost savings? | ||||
Elger CE1, Fröhlich A2, Fuchs S3 | ||||
1 Life & Brain GmbH, Bonn, Germany 2 Desitin Arzneimittel GmbH, Hamburg, Germany 3 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany | ||||
Monitor Versorgungsforschung, 2010, 03: pp. 51-54 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2010 | German | , Cost analysis | |
Designing and Implementing Health Care Provider Payment Systems. How-To Manuals. Ed by JC Langenbrunner, C Cashin, Sh. O’Dougherty, WB, 2009. Chapter 2 Case-Based Hospital Payment Systems | ||||
O’Dougherty S1, Cashin C2, Samyshkin E3, Ibraimova A4, Katsaga A5, Kutanov E1, Lyachshuk K1, Zues O6 | ||||
1 USAID ZdravPlus Project/Abt Associates Inc., Almaty, Kazakhstan 2 USAID ZdravPlus Project/Abt Associates Inc., and the Nicholas C. Petris Center for Health Care Markets and Consumer Welfare of the University of California, Berkeley USA 3 USAID ZdravPlus Project/Abt Associates Inc. and IMS Health, London, UK 4 Mandatory Health Insurance Fund of the Kyrgyz Republic, Bishkek, Kyrgyz Republic 5 USAID ZdravPlus Project/Abt Associates Inc., Toronto, Canada 6 USAID ZdravPlus Project/Abt Associates Inc., Bishkek, Kyrgyz Republic | ||||
The World Bank publications |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | , Market impact | |
Does pharmaceutical consumption improve healthcare status? | ||||
Grandfils N1, Hauser S1, Amalric F1, Le Pen C2 | ||||
1IMS Health, Puteaux, France, 2Paris Dauphine University, Paris, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24–27th October 2009 |
||||
, Abstract, Poster | ||||
, Denmark, France, Germany, Italy, Spain, Sweden, UK | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | , Economic evaluation | |
Primary care and avoidable hospitalizations: A comparative analysis between France and the UK | ||||
Mansour E1, Le Pen C2, Nestrigue C3, Amalric F1 | ||||
1IMS Health, Puteaux, Ile de France, France, 2Dauphine University, Paris, France, 3IMS Health, Puteaux, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24 -27th October 2009 |
||||
, Poster | ||||
, France, UK | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | ||
Raising the Bar in the USA: The Impact of Heightened Awareness of the Need for Health-Economic Data in the Absence of a Regulatory Mandate. | ||||
Minshall ME, Watkins J | ||||
ISPOR Connections, 2008; 14(1):9-12. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2008 | English | , Methodology | |
Programme zur Bekämpfung von Krankheiten in Entwicklungsländern [Program to fight against diseases in developing countries] | ||||
Schöffski O1, Fricke F-U2, Gabriel SC3 | ||||
1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma AG, Basel, Switzerland | ||||
Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 507-524 |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2008 | German | ||
Lungenkarzinom in Deutschland - eine kostensparende Option | ||||
Schöffski O1, Fricke FU2, Gabriel SC | ||||
1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany | ||||
Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 507-524 |
||||
, Book chapter | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2008 | German | ||
Kosten-Nutzen-Bewertungen von Arzneimitteln werden entscheidungsrelevant [Cost-benefit-assessments become relevant for decision-making]. | ||||
Fricke FU1, Schröder-Bernhardi D2 | ||||
1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt, Germany | ||||
Pharm. Ind., 69(2):160-164 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2007 | German | , Cost benefit | |
Impacto en el mercado de las políticas regionales de racionalización de la prescripción farmacéutica en Andalucía [Market impact of regional racionalization policies on pharmaceutical prescription in Andalucia] | ||||
Badia X1, Lara N1, Vieta A1 | ||||
1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
XXVII Jornadas de Economía de la Salud (AES). 2007June 6-8, La Coruña, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2007 | Spanish | , Market impact | |
Facilitating informed, health literate patients as partners in health: Development of a Direct To Patient Information Model | ||||
Vieta A | ||||
Health Economics and Outcomes Research, Barcelona, Spain | ||||
3rd World Ageing & Generations Congress 2007, September 6-8, St Gallen, Switzerland |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2007 | English | ||
Recent policy initiatives in the Australian national reimbursement system that have reduced cost dramatically | ||||
Peter Davey. | ||||
ISPOR 11th Annual International Meeting ISPOR 11th International Meeting, 20-24 May 2006 Philadelphia, Pennsylvania, USA. Podium presentation. |
||||
, Oral presentation | ||||
, Australia | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2006 | English | , Pricing & Reimbursement | |
Strategic management. Pharmaceutical generics—a changing playing field | ||||
Davey P | ||||
4th Annual Pharma Marketing & Sales Congress |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2006 | English | , Budget impact | |